Cambridge researchers are looking at ways that AI can transform everything from drug discovery to Alzheimer's diagnoses to GP consultations.
Antibiotics, antivirals, vaccinations and anti-inflammatory medication are associated with reduced risk of dementia, according to new research that...
What excites Steve Jackson is understanding how biology works and why it sometimes goes wrong. But what galvanises him is knowing there are people...
Researchers have used artificial intelligence techniques to massively accelerate the search for Parkinson’s disease treatments.
Researchers have developed a platform that combines automated experiments with AI to predict how chemicals will react with one another, which could...
̽»¨Ö±²¥facility, based at the Milner Therapeutics Institute, will support the discovery of new medicines and diagnostics for chronic diseases by...
Researchers have developed a method to identify new targets for human disease, including neurodegenerative conditions such as Alzheimer’s disease.
Vector Bioscience has received a £2.2 million investment to help it take forward its drug delivery platform designed to make RNA cancer therapies...
A ̽»¨Ö±²¥ of Cambridge spin-out company from the Cavendish Laboratory, combines materials engineering and cell biology to help biopharma companies...
Cambridge's Experimental Medicine Initiative, working with AstraZeneca and GSK, is training specialists who can work out at an earlier stage of...
Researchers have developed a new approach to machine learning that ‘learns how to learn’ and out-performs current machine learning methods for drug...
Professor Steve Jackson talks about drug discovery, serial entrepreneurship and the enterprising mindset.
